RUVOLETTO, MARIAGRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 4.466
AS - Asia 3.354
EU - Europa 1.427
SA - Sud America 533
AF - Africa 458
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 16
Totale 10.295
Nazione #
US - Stati Uniti d'America 4.196
SG - Singapore 1.030
VN - Vietnam 607
CN - Cina 602
HK - Hong Kong 402
BR - Brasile 333
IT - Italia 257
DE - Germania 163
FI - Finlandia 132
FR - Francia 108
SE - Svezia 108
PL - Polonia 102
IN - India 97
GB - Regno Unito 70
RU - Federazione Russa 47
NL - Olanda 46
BD - Bangladesh 44
MX - Messico 42
PH - Filippine 42
TR - Turchia 42
CA - Canada 41
JP - Giappone 40
AR - Argentina 37
AT - Austria 35
IQ - Iraq 35
ES - Italia 32
UA - Ucraina 32
ZA - Sudafrica 32
PK - Pakistan 29
CO - Colombia 27
ID - Indonesia 27
IE - Irlanda 27
EC - Ecuador 23
JO - Giordania 23
MA - Marocco 22
VE - Venezuela 22
AE - Emirati Arabi Uniti 21
KR - Corea 20
PY - Paraguay 20
SA - Arabia Saudita 20
AL - Albania 19
CL - Cile 19
UZ - Uzbekistan 19
AO - Angola 18
CI - Costa d'Avorio 17
LB - Libano 17
MN - Mongolia 17
BB - Barbados 16
BF - Burkina Faso 16
CY - Cipro 16
CZ - Repubblica Ceca 16
IR - Iran 16
JM - Giamaica 16
KZ - Kazakistan 16
LY - Libia 16
PA - Panama 16
PE - Perù 16
AZ - Azerbaigian 15
ET - Etiopia 15
LC - Santa Lucia 15
NI - Nicaragua 15
TW - Taiwan 15
CH - Svizzera 14
CM - Camerun 14
CU - Cuba 14
DJ - Gibuti 14
KG - Kirghizistan 14
MY - Malesia 14
RO - Romania 14
TH - Thailandia 14
BO - Bolivia 13
CR - Costa Rica 13
DZ - Algeria 13
LA - Repubblica Popolare Democratica del Laos 13
MK - Macedonia 13
PS - Palestinian Territory 13
PT - Portogallo 13
SK - Slovacchia (Repubblica Slovacca) 13
BZ - Belize 12
GH - Ghana 12
HR - Croazia 12
HU - Ungheria 12
IS - Islanda 12
KE - Kenya 12
MR - Mauritania 12
SD - Sudan 12
UY - Uruguay 12
CG - Congo 11
EG - Egitto 11
GN - Guinea 11
GR - Grecia 11
ML - Mali 11
NZ - Nuova Zelanda 11
TJ - Tagikistan 11
YT - Mayotte 11
CV - Capo Verde 10
GT - Guatemala 10
KH - Cambogia 10
MU - Mauritius 10
SN - Senegal 10
Totale 9.858
Città #
Singapore 647
San Jose 563
Ashburn 532
Hong Kong 361
Chandler 303
Fairfield 299
Woodbridge 197
Ho Chi Minh City 181
Jacksonville 157
Hanoi 147
Wilmington 139
Houston 137
Ann Arbor 132
Santa Clara 126
Los Angeles 119
Beijing 113
Seattle 99
Boardman 92
Cambridge 90
Padova 77
Bytom 70
Helsinki 63
New York 58
Lauterbourg 54
Nanjing 51
Princeton 50
Des Moines 45
Medford 39
Munich 37
Da Nang 34
San Diego 32
São Paulo 32
Council Bluffs 31
Hefei 30
Haiphong 28
Roxbury 27
Tokyo 27
Buffalo 26
Frankfurt am Main 26
Warsaw 26
Dearborn 24
Turku 24
Amman 23
Chicago 23
Dublin 23
London 23
Nuremberg 21
Montreal 20
Orem 20
Dallas 19
Guangzhou 18
Johannesburg 18
Abidjan 17
Tashkent 17
Atlanta 16
Chennai 16
Milan 16
Padua 16
Panama City 16
Ulan Bator 16
Baku 15
Dong Ket 15
Luanda 15
Phoenix 15
Shenyang 15
Stockholm 15
The Dalles 15
Vienna 15
Castries 14
Denver 14
Lahore 14
Managua 14
Shanghai 14
Biên Hòa 13
San Francisco 13
Tirana 13
Addis Ababa 12
Boston 12
Bridgetown 12
Brooklyn 12
Changsha 12
Djibouti 12
Havana 12
Hải Dương 12
Istanbul 12
Jinan 12
Nouakchott 12
Pune 12
Rio de Janeiro 12
Vientiane 12
Accra 11
Amsterdam 11
Baghdad 11
Bishkek 11
Guayaquil 11
Nha Trang 11
Rome 11
Tianjin 11
Abu Dhabi 10
Asunción 10
Totale 6.188
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 383
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 340
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 295
Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus 253
Serpin B3 differently up-regulates hypoxia inducible factors -1α and -2α in hepatocellula arcinoma: Mechanisms revealing novel potential therapeutic targets 246
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 233
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 232
SERPINB3 induces epithelial-mesenchymal transition. 230
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer 229
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 228
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 227
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 224
Hepatic progenitor cells express SerpinB3 218
SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection 216
Engineered EVs for oxidative stress protection 209
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 208
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 207
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 204
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 198
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 194
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 192
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 192
SerpinB3 administration protects liver against ischemia-reperfusion injury 191
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 191
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 188
SQUAMOUS CELL CARCINOMA ANTIGEN VARIANTS OVEREXPRESSION IN HEPATOCELLULAR CARCINOMA. 187
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 181
1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2 180
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 176
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 172
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 171
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 163
Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici 159
Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 in HepG2 cells 158
Circulating Squamous Cell Carcinoma Antigen-IgM complexes as novel biomarkers for hepatocellular carcinoma 156
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 153
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 153
DEREGOLAZIONE DELL’ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) NEI LINFOCITI B IN PAZIENTI INFETTI DA HCV 146
SERPINB3 modulates TGF-beta expression in chronic liver disease. 145
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 144
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 137
SCCA overexpression induces cell proliferation and down-regulation of the adhesion system 136
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 135
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 135
HCC invasiveness induced by SCCA is associated with nuclear beta-catenin accumulation 130
Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid 128
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 123
Does HCV infection have a more favourable outcome in Tanzanian people? Data from the Lugalawa study 121
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 118
A New Assay for Quantitative Determination of Pres1-Encoded Protein in Patients Infected with Hepatitis B and Delta Viruses 116
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 111
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 109
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 106
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 103
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 97
DETERMINAZIONE DELL’IMMUNOCOMPLESSO VEGF-IgM NELL’ EPATOCARCINOMA 96
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 90
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 85
The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma 82
Totale 10.330
Categoria #
all - tutte 27.434
article - articoli 21.475
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 402
selected - selezionate 0
volume - volumi 0
Totale 49.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 0 56 86
2021/2022475 10 87 56 35 12 32 20 41 12 7 57 106
2022/2023594 92 63 21 66 100 99 0 51 72 3 20 7
2023/2024327 6 59 46 26 35 45 21 12 4 13 29 31
2024/20251.555 8 162 55 75 148 50 77 104 96 78 301 401
2025/20265.835 314 480 740 825 577 272 1.150 474 582 292 129 0
Totale 10.330